These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 38825983)
21. Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors. Pfaff N; Liebhaber S; Möbus S; Beh-Pajooh A; Fiedler J; Pfanne A; Schambach A; Thum T; Cantz T; Moritz T Stem Cell Res; 2017 Apr; 20():70-75. PubMed ID: 28314201 [TBL] [Abstract][Full Text] [Related]
22. A PIANO (Proper, Insufficient, Aberrant, and NO Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming. Hu K Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370214 [TBL] [Abstract][Full Text] [Related]
23. Acceleration of somatic cell reprogramming into the induced pluripotent stem cell using a mycosporine-like amino acid, Porphyra 334. Yoo J; Kim J; Lee JH; Kim H; Jang SJ; Seo HH; Oh ST; Hyeon SJ; Ryu H; Kim J; Moh SH Sci Rep; 2020 Feb; 10(1):3684. PubMed ID: 32111890 [TBL] [Abstract][Full Text] [Related]
24. Diversity of dermal fibroblasts as major determinant of variability in cell reprogramming. Sacco AM; Belviso I; Romano V; Carfora A; Schonauer F; Nurzynska D; Montagnani S; Di Meglio F; Castaldo C J Cell Mol Med; 2019 Jun; 23(6):4256-4268. PubMed ID: 30980516 [TBL] [Abstract][Full Text] [Related]
25. Direct Reprogramming of Fibroblasts to Astrocytes Using Small Molecules. Tian E; Zhang M; Shi Y Methods Mol Biol; 2021; 2352():45-55. PubMed ID: 34324179 [TBL] [Abstract][Full Text] [Related]
26. Modulation of the EMT/MET process by pyrrole-imidazole polyamide targeting human transforming growth factor-β1. Saito K; Fukuda N; Shinohara K; Masuhiro Y; Hanazawa S; Matsuda H; Fujiwara K; Ueno T; Soma M Int J Biochem Cell Biol; 2015 Sep; 66():112-20. PubMed ID: 26222185 [TBL] [Abstract][Full Text] [Related]
27. A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs. Neganova I; Chichagova V; Armstrong L; Lako M Sci Rep; 2017 Feb; 7():41693. PubMed ID: 28155868 [TBL] [Abstract][Full Text] [Related]
28. Stiffness of Hydrogels Regulates Cellular Reprogramming Efficiency Through Mesenchymal-to-Epithelial Transition and Stemness Markers. Choi B; Park KS; Kim JH; Ko KW; Kim JS; Han DK; Lee SH Macromol Biosci; 2016 Feb; 16(2):199-206. PubMed ID: 26439948 [TBL] [Abstract][Full Text] [Related]
29. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype. Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541 [TBL] [Abstract][Full Text] [Related]
30. Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival. Robertson A; Mohamed TM; El Maadawi Z; Stafford N; Bui T; Lim DS; Cartwright EJ; Oceandy D Stem Cell Res; 2017 Apr; 20():42-49. PubMed ID: 28257933 [TBL] [Abstract][Full Text] [Related]
31. Knockdown H19 Accelerated iPSCs Reprogramming through Epigenetic Modifications and Mesenchymal-to-Epithelial Transition. Sun R; Zhang X; Gong T; Zhang Y; Wang Q; He C; Ju J; Jin C; Ding W; Gao J; Shen J; Li Q; Shan Z Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785917 [TBL] [Abstract][Full Text] [Related]
32. Generation of intermediate porcine iPS cells under culture condition favorable for mesenchymal-to-epithelial transition. Zhang S; Guo Y; Cui Y; Liu Y; Yu T; Wang H Stem Cell Rev Rep; 2015 Feb; 11(1):24-38. PubMed ID: 25134796 [TBL] [Abstract][Full Text] [Related]
33. Small RNA-mediated regulation of iPS cell generation. Li Z; Yang CS; Nakashima K; Rana TM EMBO J; 2011 Mar; 30(5):823-34. PubMed ID: 21285944 [TBL] [Abstract][Full Text] [Related]
34. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation. Zhang J; Cao H; Xie J; Fan C; Xie Y; He X; Liao M; Zhang S; Wang H Cell Death Dis; 2018 Feb; 9(2):224. PubMed ID: 29445086 [TBL] [Abstract][Full Text] [Related]
35. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells. Febbraro F; Chen M; Denham M Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617 [TBL] [Abstract][Full Text] [Related]
36. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins. Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118 [TBL] [Abstract][Full Text] [Related]
37. p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming. Martin-Lopez M; Maeso-Alonso L; Fuertes-Alvarez S; Balboa D; Rodríguez-Cortez V; Weltner J; Diez-Prieto I; Davis A; Wu Y; Otonkoski T; Flores ER; Menéndez P; Marques MM; Marin MC Cell Death Dis; 2017 Sep; 8(9):e3034. PubMed ID: 28880267 [TBL] [Abstract][Full Text] [Related]
38. N-Cadherin Nanoantagonist Driven Mesenchymal-to-Epithelial Transition in Fibroblasts for Improving Reprogramming Efficiency. Meng X; Zhou A; Huang Y; Zhang Y; Xu Y; Shao K; Ning X Nano Lett; 2021 Jul; 21(13):5540-5546. PubMed ID: 34161107 [TBL] [Abstract][Full Text] [Related]
39. Suppression of the ERK-SRF axis facilitates somatic cell reprogramming. Huh S; Song HR; Jeong GR; Jang H; Seo NH; Lee JH; Yi JY; Lee B; Choi HW; Do JT; Kim JS; Lee SH; Jung JW; Lee T; Shim J; Han MK; Lee TH Exp Mol Med; 2018 Feb; 50(2):e448. PubMed ID: 29472703 [TBL] [Abstract][Full Text] [Related]